348 related articles for article (PubMed ID: 12391245)
1. Selective suppression of neutrophil accumulation in ongoing pulmonary inflammation by systemic inhibition of p38 mitogen-activated protein kinase.
Nick JA; Young SK; Arndt PG; Lieber JG; Suratt BT; Poch KR; Avdi NJ; Malcolm KC; Taube C; Henson PM; Worthen GS
J Immunol; 2002 Nov; 169(9):5260-9. PubMed ID: 12391245
[TBL] [Abstract][Full Text] [Related]
2. Role of p38 mitogen-activated protein kinase in a murine model of pulmonary inflammation.
Nick JA; Young SK; Brown KK; Avdi NJ; Arndt PG; Suratt BT; Janes MS; Henson PM; Worthen GS
J Immunol; 2000 Feb; 164(4):2151-9. PubMed ID: 10657669
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory effects of LASSBio-998, a new drug candidate designed to be a p38 MAPK inhibitor, in an experimental model of acute lung inflammation.
Brando Lima AC; Machado AL; Simon P; Cavalcante MM; Rezende DC; Sperandio da Silva GM; Nascimento PG; Quintas LE; Cunha FQ; Barreiro EJ; Lima LM; Koatz VL
Pharmacol Rep; 2011; 63(4):1029-39. PubMed ID: 22001991
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of lipopolysaccharide-induced cyclooxygenase-2 expression in human neutrophils: involvement of the mitogen-activated protein kinase pathway and regulation by anti-inflammatory cytokines.
Nagano S; Otsuka T; Niiro H; Yamaoka K; Arinobu Y; Ogami E; Akahoshi M; Inoue Y; Miyake K; Nakashima H; Niho Y; Harada M
Int Immunol; 2002 Jul; 14(7):733-40. PubMed ID: 12096032
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory effects of a p38 mitogen-activated protein kinase inhibitor during human endotoxemia.
Branger J; van den Blink B; Weijer S; Madwed J; Bos CL; Gupta A; Yong CL; Polmar SH; Olszyna DP; Hack CE; van Deventer SJ; Peppelenbosch MP; van der Poll T
J Immunol; 2002 Apr; 168(8):4070-7. PubMed ID: 11937566
[TBL] [Abstract][Full Text] [Related]
6. SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung.
Underwood DC; Osborn RR; Bochnowicz S; Webb EF; Rieman DJ; Lee JC; Romanic AM; Adams JL; Hay DW; Griswold DE
Am J Physiol Lung Cell Mol Physiol; 2000 Nov; 279(5):L895-902. PubMed ID: 11053025
[TBL] [Abstract][Full Text] [Related]
7. p38 Mitogen-activated protein kinase up-regulates LPS-induced NF-kappaB activation in the development of lung injury and RAW 264.7 macrophages.
Kim HJ; Lee HS; Chong YH; Kang JL
Toxicology; 2006 Aug; 225(1):36-47. PubMed ID: 16793190
[TBL] [Abstract][Full Text] [Related]
8. Cleavage of mitogen-activated protein kinases in human neutrophils undergoing apoptosis: role in decreased responsiveness to inflammatory cytokines.
Suzuki K; Hasegawa T; Sakamoto C; Zhou YM; Hato F; Hino M; Tatsumi N; Kitagawa S
J Immunol; 2001 Jan; 166(2):1185-92. PubMed ID: 11145700
[TBL] [Abstract][Full Text] [Related]
9. Role of p38 mitogen-activated protein kinase in chemokine-induced emigration and chemotaxis in vivo.
Cara DC; Kaur J; Forster M; McCafferty DM; Kubes P
J Immunol; 2001 Dec; 167(11):6552-8. PubMed ID: 11714824
[TBL] [Abstract][Full Text] [Related]
10. p38 mitogen-activated protein kinase activation is required for human neutrophil function triggered by TNF-alpha or FMLP stimulation.
Zu YL; Qi J; Gilchrist A; Fernandez GA; Vazquez-Abad D; Kreutzer DL; Huang CK; Sha'afi RI
J Immunol; 1998 Feb; 160(4):1982-9. PubMed ID: 9469462
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological inhibition of p38 mitogen-activated protein kinases affects KC/CXCL1-induced intraluminal crawling, transendothelial migration, and chemotaxis of neutrophils in vivo.
Xu N; Hossain M; Liu L
Mediators Inflamm; 2013; 2013():290565. PubMed ID: 23533303
[TBL] [Abstract][Full Text] [Related]
12. The p38 mitogen-activated protein kinase mediates cytoskeletal remodeling in pulmonary microvascular endothelial cells upon intracellular adhesion molecule-1 ligation.
Wang Q; Doerschuk CM
J Immunol; 2001 Jun; 166(11):6877-84. PubMed ID: 11359848
[TBL] [Abstract][Full Text] [Related]
13. Blockade of p38 map kinase inhibits complement-induced acute lung injury in a murine model.
Nash SP; Heuertz RM
Int Immunopharmacol; 2005 Dec; 5(13-14):1870-80. PubMed ID: 16275622
[TBL] [Abstract][Full Text] [Related]
14. In vivo role of p38 mitogen-activated protein kinase in mediating the anti-inflammatory effects of CpG oligodeoxynucleotide in murine asthma.
Choudhury BK; Wild JS; Alam R; Klinman DM; Boldogh I; Dharajiya N; Mileski WJ; Sur S
J Immunol; 2002 Nov; 169(10):5955-61. PubMed ID: 12421981
[TBL] [Abstract][Full Text] [Related]
15. MAPK-activated protein kinase-2 participates in p38 MAPK-dependent and ERK-dependent functions in human neutrophils.
Coxon PY; Rane MJ; Uriarte S; Powell DW; Singh S; Butt W; Chen Q; McLeish KR
Cell Signal; 2003 Nov; 15(11):993-1001. PubMed ID: 14499342
[TBL] [Abstract][Full Text] [Related]
16. Selective activation and functional significance of p38alpha mitogen-activated protein kinase in lipopolysaccharide-stimulated neutrophils.
Nick JA; Avdi NJ; Young SK; Lehman LA; McDonald PP; Frasch SC; Billstrom MA; Henson PM; Johnson GL; Worthen GS
J Clin Invest; 1999 Mar; 103(6):851-8. PubMed ID: 10079106
[TBL] [Abstract][Full Text] [Related]
17. Selective activation of p38 mitogen-activated protein kinase cascade in human neutrophils stimulated by IL-1beta.
Suzuki K; Hino M; Kutsuna H; Hato F; Sakamoto C; Takahashi T; Tatsumi N; Kitagawa S
J Immunol; 2001 Nov; 167(10):5940-7. PubMed ID: 11698472
[TBL] [Abstract][Full Text] [Related]
18. Role of p38 MAP kinase in LPS-induced airway inflammation in the rat.
Haddad EB; Birrell M; McCluskie K; Ling A; Webber SE; Foster ML; Belvisi MG
Br J Pharmacol; 2001 Apr; 132(8):1715-24. PubMed ID: 11309243
[TBL] [Abstract][Full Text] [Related]
19. Kinase pathways in chemoattractant-induced degranulation of neutrophils: the role of p38 mitogen-activated protein kinase activated by Src family kinases.
Mócsai A; Jakus Z; Vántus T; Berton G; Lowell CA; Ligeti E
J Immunol; 2000 Apr; 164(8):4321-31. PubMed ID: 10754332
[TBL] [Abstract][Full Text] [Related]
20. Urokinase-type plasminogen activator potentiates lipopolysaccharide-induced neutrophil activation.
Abraham E; Gyetko MR; Kuhn K; Arcaroli J; Strassheim D; Park JS; Shetty S; Idell S
J Immunol; 2003 Jun; 170(11):5644-51. PubMed ID: 12759445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
